ArticleVaccine2020
Contingent assessment of the COVID-19 vaccine.
Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
92 citing papers in PubMed, 2 syntheses or guidelines pooled it, 157 citations in OpenAlex.
- Factors associated with COVID-19 vaccine intentions during the COVID-19 pandemic; a systematic review and meta-analysis of cross-sectional studies.BMC public health · 2022Pooled it
- Evaluation of the Acceptance Rate of Covid-19 Vaccine and its Associated Factors: A Systematic Review and Meta-analysis.Journal of prevention (2022) · 2022Pooled it
- Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.PloS one · 2021Trial
- Knowledge, preventive behaviors and risk perception of the COVID-19 pandemic: A cross-sectional study in Turkish health care workers.PloS one · 2021Trial
- Willingness to Pay for the COVID-19 Vaccine and Its Correlates in Bangladesh: Cross-Sectional Study.JMIRx med · 2025Article
- Associations Between Psychosocial Influence, Positive Thinking, and Vaccine Attitudes in Patients with Schizophrenia During the COVID-19 Pandemic.Psychology research and behavior management · 2025Article
- The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems.Pharmaceutics · 2024Review
- Assessing willingness to pay for children's COVID-19 vaccination among healthcare providers and users using a theory-based discrete choice experiment.Scientific reports · 2024Article
- Individuals' willingness to pay for HIV vaccines in Iran: Contingent valuation method.Health science reports · 2024Article
- Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country.PharmacoEconomics - open · 2024Article
- Sociodemographic determinants of vaccination and willingness to pay for COVID-19 vaccines in Hungary, results of a cross-sectional online questionnaire.BMC public health · 2024Article
- Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.Israel journal of health policy research · 2024Article
- COVID-19 vaccine literacy: A scoping review.Human vaccines & immunotherapeutics · 2023Article
- Coronavirus Disease Vaccination Among Persons With Disabilities: Understanding Vaccine Perceptions and Hesitancy in Ghana.The Linacre quarterly · 2023Article
- Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries.PharmacoEconomics · 2023Article
- Investigating preferences of the covid-19 vaccine among individuals in Iran: Discrete choice experiment analysis.Health science reports · 2023Article
- Willingness to pay for a COVID-19 vaccine and its associated determinants in Iran.Frontiers in public health · 2023Article
- The main decision-making competence for willingness-to-pay towards COVID-19 vaccination: a family-based study in Taizhou, China.Annals of medicine · 2022Article
- Impacts of Vaccination on International Trade During the Pandemic Era.The Developing economies · 2022Article
- Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method.Research in social & administrative pharmacy : RSAP · 2022Article
32 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has not only had a negative impact on people's health and life behavior, but also on economies around the world. At the same time, laboratories and institutions are working hard to obtain a COVID-19 vaccine, which we hope will be available soon. However, there has been no assessment of whether an individual and society value a vaccine monetarily, and what factors determine this value. Therefore, the objective of this research was to estimate the individual's willingness to pay (WTP) for a hypothetical COVID-19 vaccine and, at the same time, find the main factors that determine this valuation. For this, we used the contingent valuation approach, in its single and double-bounded dichotomous choice format, which was based on a hypothetical market for a vaccine. The sample used was obtained through an online survey of n = 566 individuals from Chile. The main results showed that the WTP depends on the preexistence of chronic disease (p≤0.05), knowledge of COVID-19 (p≤0.05), being sick with COVID-19 (p≤0.05), perception of government performance (p≤0.01), employment status (p≤0.01), income (p≤0.01), health care (p≤0.05), adaptation to quarantine with children at home (p≤0.01) and whether the person has recovered from COVID-19 (p≤0.10). According to our discrete choice model in double-bounded dichotomous format, it was concluded that the individuals' WTP is US$184.72 (CI: 165.52-203.92; p < 0.01). This implies a social valuation of approximately US$2232 million, corresponding to 1.09% of the GNP per capita.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.